RECRUITING

Hyperbaric Oxygen Therapy in Acute Ischemic Stroke Ischemic Stroke Recovery (Pro00061930)

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study will critically examine the feasibility, safety and efficacy of HBOT during inpatient rehabilitation (IPR) after acute ischemic stroke measured by non-disruption of 3 hours of daily therapy, frequency of neurological deterioration or complications (seizure, hemorrhage, brain edema), and functional communication, activities of daily living (ADLs) and mobility.

Official Title

Hyperbaric Oxygen Therapy in Acute Ischemic Stroke Recovery

Quick Facts

Study Start:2022-05-24
Study Completion:2026-12-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06148285

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Age 18 years and above
  2. * Ischemic stroke proven on neuroimaging
  3. * Within 7-30 days post-stroke on day 1 of treatment
  4. * Admitted to Touro Inpatient Rehab Facility
  1. * Pre-stroke modified Rankin Scale Score \>2
  2. * Parenchymal hemorrhagic transformation (PH1 or PH2)
  3. * Receptive aphasia such that recommendations for preventative measures to mitigate barotrauma cannot be followed
  4. * History of recurrent and unprovoked seizures requiring a change in management in the last 3 months to control seizures
  5. * Pulmonary disease requiring supplemental oxygen or daily respiratory medication management (metered dose inhalers, nebulized treatment or steroids)

Contacts and Locations

Study Contact

Lawrence Matarutse
CONTACT
504-962-6419
Lawrence.Matarutse@lcmchealth.org
Sheryl Martin-Schild, MD, PhD
CONTACT
504-982-3278
sheryl.martin-schild@lcmchealth.org

Study Locations (Sites)

Touro Infirmary New Orleans
New Orleans, Louisiana, 70112
United States

Collaborators and Investigators

Sponsor: LCMC Health

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-05-24
Study Completion Date2026-12-31

Study Record Updates

Study Start Date2022-05-24
Study Completion Date2026-12-31

Terms related to this study

Additional Relevant MeSH Terms

  • Acute Ischemic Stroke